Physician

Internal Medicine

Dr. Vibha N. Lama is an expert in the field of Internal Medicine. She graduated from Wayne State University School of Medicine. Wayne State University School of Medicine has a rank of 63 in research and a 85 in primary care She over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Vibha Lama is also a published doctor. She has 31 paper published. The most recent paper is: The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyper... Vibha N. Lama accepts all Medicare patients.

Publications

---

• The relationship between plasma lipid peroxidation products and primary graft dysfunction after Lung transplantation is modified by donor smoking and reperfusion hyper...
• Analysis of Culture-Dependent versus Culture-Independent Techniques for Identification of Bacteria in Clinically Obtained Bronchoalveolar Lavage Fluid.
• Plasma complement levels are associated with primary graft dysfunction and mortality after Lung transplantation.
• Lung microbiome and disease progression in idiopathic Pulmonary fibrosis: an analysis of the COMET study.
• Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after Lung transplantation.
• Preoperative Pulmonary artery pressure and mortality after lung transplantation.
• Lysophosphatidic Acid Induces Migration of Human Lung-Resident Mesenchymal Stem Cells Through the β-Catenin Pathway.
• Prostaglandin E2 as an Inhibitory Modulator of Fibrogenesis in Human Lung Allografts.
• Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human Lung allografts.
• Mesenchymal stromal cells in bronchoalveolar lavage as predictors of Bronchiolitis obliterans syndrome.
• Epithelial Interactions and Local Engraftment of Lung-resident Mesenchymal Stem Cells.
• Ecto-5'-nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulation.
• Soluble p-selectin and the risk of primary graft dysfunction after Lung transplantation.
• Update in Lung transplantation 2008.
• Lung resident mesenchymal stem cells isolated from human Lung allografts inhibit T cell proliferation via a soluble mediator.
• Early growth response gene-1 promotes airway allograft rejection.
• Lung cells from neonates show a mesenchymal stem cell phenotype.
• Course of FEV(1) after onset of Bronchiolitis obliterans syndrome in lung transplant recipients.
• Evidence for tissue-resident mesenchymal stem cells in human adult Lung from studies of transplanted allografts.
• Surgical patient outcomes after the increased use of bilateral Lung transplantation.
• Obligatory role for interleukin-13 in Obstructive lesion development in airway allografts.
• The extraPulmonary origin of fibroblasts: stem/progenitor cells and beyond.
• Carbon monoxide rescues ischemic Lungs by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genes.
• Prognostic value of Bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients.
• Reciprocal regulation of airway rejection by the inducible gas-forming enzymes heme oxygenase and nitric oxide synthase.
• Idiopathic Interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?
• Resting and exercise physiology in interstitial lung Diseases.
• Prognostic value of desaturation during a 6-minute walk test in idiopathic Interstitial pneumonia.
• Cell-associated bacteria in the human Lung microbiome.
• Changes in the Lung Microbiome following Lung Transplantation include the Emergence of Two Distinct Pseudomonas Species with Distinct Clinical Associations.

Schools

---

• Dayanand Medical College Baba Farid University Of Health Sciences

• University Of Mi Hosps and Health Ctrs

• Wayne St University Detroit M C

Procedures Preformed

---

• Bronchoscopy
• Thoracentesis
• Ventilation Management

Conditions Treated

---

• Acidosis
• Asthma
• Atelectasis
• Bronchiectasis
• View All

Doctors Specialties

---

• Critical Care Medicine
• Pulmonology
• Internal Medicine

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification

Education

---

• University of Michigan Hospitals and Health Centers
• Wayne State University School of Medicine
• Dayanand Medical College

Hospital

---

• University of Michigan Hospitals and Health Centers

Drug Facts

---

NPI NUMBER		1255413167
NPPES Provider LastName		LAMA
NPPES Provider FirstName		VIBHA
NPPES Provider ZIPCode		481095360
NPPES Provider State		MI
Specialty Description		Pulmonary Disease
Total Claim Count		433.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1255413167
Last Name Of The Provider	LAMA
First Name Of The Provider	VIBHA
View All

Similar Doctors

---

	Dr. John P. Schmidt, MD This Doctor is OpenDoctor Recommended.
	Dr. Binju Joel, MD This Doctor is OpenDoctor Recommended.
	Dr. Jennifer P. Waugh, MD
	Dr. Mosmi N. Surati, MD This Doctor is OpenDoctor Recommended.
	Dr. Elizabeth A. Belloli, MD This Doctor is OpenDoctor Recommended.
	Dr. Margaret R. Gyetko, MD This Doctor is OpenDoctor Recommended.
	Dr. Christopher L. Tyler, MD
	Dr. Lauryn R. Rochlen, MD This Doctor is OpenDoctor Recommended.
	Dr. William L. Eschenbacher, MD
	Dr. Raju C. Reddy, MD
	Dr. Adam C. Jenkins, MD
	Dr. Jessica L. Tsui, MD
	Vishal Abiraj, MB BS This Doctor is OpenDoctor Recommended.
	Carl D. Koch, MC

---

Doctor Directory | TOS | twitter | FB | Angel | blog